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Chitin, the second most abundant polysaccharide in nature 
after cellulose, consist exoskeleton of lower organisms such 
as fungi, crustaceans and insects except mammals. Recently, 
several studies evaluated immunologic effects of chitin in vivo 
and in vitro and revealed new aspects of chitin regulation of 
innate and adaptive immune responses. It has been shown that 
exogenous chitin activates macrophages and other innate 
immune cells and also modulates adaptive type 2 allergic in-
flammation. These studies further demonstrate that chitin 
stimulate macrophages by interacting with different cell surface 
receptors such as macrophage mannose receptor, toll-like 
receptor 2 (TLR-2), C-type lectin receptor Dectin-1, and 
leukotriene B4 recepptor (BLT1). On the other hand, a number 
of chitinase or chitinase-like proteins (C/CLP) are ubiquitously 
expressed in the airways and intestinal tracts from insects to 
mammals. In general, these chitinase family proteins confer 
protective functions to the host against exogenous chitin-con-
taining pathogens. However, substantial body of recent studies 
also set light on new roles of C/CLP in the development and 
progression of allergic inflammation and tissue remodeling. In 
this review, recent findings on the role of chitin and C/CLP 
in allergic inflammation and tissue remodeling will be 
highlighted and controversial and unsolved issues in this field 
of studies will be discussed.
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INTRODUCTION
Chitin,  β-(1-4)-poly-N-acetyl D-glucosamine, is 
widely distributed in nature and is the second 
most abundant polysaccharide in nature after 
cellulose. It is found in the cell walls of bacteria 
and fungi, mushrooms, exoskeleton of crustaceans 
(crabs, shrimp, etc.) and insects, the microfilarial 
sheath of parasitic nematodes, and the lining of 
the digestive tracts of many insect.
1-8 In these 
locations, chitin is used by the chitin-containing 
organisms to protect it from the harsh conditions 
in its environment and host anti-parasite/patho-
gen immune responses. The mammalian counter-
part of chitin has not been described. Despite its 
ubiquity, chitin does not accumulate in the environ-
ment mainly because chitinolytic bacteria or 
saprophytes efficiently recycle most of chitin.
9 As 
some chitin derivatives are known to be non- 
toxic, non-allergenic, biodegradable, and biocom-
patible, a number of prostheses such as artificial 
skin, contact lenses, surgical stitches have been 
produced from chitin derivatives and are widely 
used in medical practice.
10 Thus, it is very com-
mon for humans to be exposed to chitin/chitin 
derivatives in daily life.
Although mammals cannot synthesize or meta-
bolize chitin, a number of chitinolytic enzymes [true 
chitinases, e.g., chitotriosidases, acidic mammalian 
chitinase (AMCase)] or chitin-binding proteins 
[chitinase-like proteins (CLPs), e.g., Ym-1, Ym-2, 
breast regression protein 39 (BRP-39, chondrocyte 
protein-39)] were discovered in mammals.
5,11  Many 
of the chitinase family proteins are constitutively 
expressed in macrophages and epithelial cells of 
the lung and digestive tracts, consisting of the 
body's first line of defense against exogenous 
agents including chitin-containing pathogens.
12,13 
Interestingly, some of the chitinases or CLPs (C/ 
CLPs) have been reported to be expressed in a 
inducible manner in certain inflammatory and 
allergic conditions.
14-16 Increased expression of 
AMCase in the lung was reported in the develop-Immune Regulation of Chitin and Chitinases 23
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ment of Th2 inflammation in allergic animal 
models and the human asthmatic airway.
14  Genetic 
studies in human populations have shown linked 
polymorphisms in AMCase to asthma suscepti-
bility in children, suggesting that inherent defects 
in this chitinase could underlie airway inflamma-
tion and allergic responses.
17  Recently, a similar 
role has been proposed with a chitinase-like pro-
tein YKL-40. The serum and tissue expression of 
YKL-40 was significantly correlated with the seve-
rity of asthma, and genetic association of serum 
YKL levels and asthmatic airways has been iden-
tified.
18,19  These studies also raise the possibility 
that the chitin, as a major binding partner of C/ 
CLPs in mammals, might play an important role 
as a modulator (initiator or enhancer) of allergic 
immune responses, in that C/CLPs play a critical 
role. However, interactions between chitin and 
C/CLPs have not been adequately studied.
CHITIN REGULATES INNATE IMMUE 
RESPONSES
Two decades ago, a number of studies demon-
strated that chitin and chitin derivatives stimulated 
macrophages to produce cytokines that confer 
non-specific host resistance to bacterial and viral 
infections and anti-tumor activity.
19-24
Since then, a number of studies describing more 
specific immunologic activities of chitin have been 
reported. Shibata et al. re-evaluated the immuno-
logical effects of chitin in vivo and in vitro using 
phagocytosable small-sized chitin particles that 
demonstrated significant priming effects of chitin 
particles in alveolar macrophages and NK cells in 
mice.25 They showed intravenous administration 
of fractionated chitin particles (1 to 10 μm) into the 
lung activates alveolar macrophages to express 
cytokines such as IL-12, tumor necrosis factor 
(TNF)-ɑ, and IL-18, leading to INF-γ production 
mainly by NK cells.
25 Subsequent studies by the 
same group of investigators demonstrated that the 
cytokine production was through a mannose- 
receptor mediated phagocytosis process.
26 The 
macrophage plasma membrane mannose receptors 
serve to mediate the internalization of the chitin 
particles that, eventually, are degraded by the 
lysozyme and N-acetyl-β-glucosaminidase in the 
macrophages of human and experimental animals.
27 
Those studies were the first demonstration of the 
direct interactions between chitin and cell surface 
receptors and raised the possibility that chitin 
uses specific signaling pathways in immune regu-
lation. 
Recently, intriguing direct in vivo immune modu-
latory function of chitin has been described.
28 The 
investigators administrated chitin beads directly 
into the lungs of mice expressing a green fluores-
cent protein (GFP)-enhanced transcript of IL-4 (4get 
mice) via intranasal application. Within several 
hours after chitin exposure, IL-4 GFP positive 
cells, in particular eosinophils (GFP+, siglec F+) 
and basophils (GFP+, IgE+, cKit-), were recruited 
to the lungs of these mice. The chitin-induced eosi-
nophil recruitment was shown to be dependent on 
leukotriene B4, because eosinophilic recruitment 
was significantly decreased in the leukotriene B4 
receptor null mice (BLT1). They further demon-
strated that chitin alternatively activates alveolar 
macrophages and macrophage response was 
critical event in recruitment of eosinophils because 
depletion of macrophages by clodronate liposome 
treatment prevented recruitment of eosinophils. 
These studies raise the possibility that chitin can 
be directly involved in the generation of allergic 
responses and provide another clues to explain high 
asthma frequency in the workers predicted to 
have high environmental exposure of chitin.
29,30 
CHITIN MODULATES ADAPTIVE TYPE 2 
IMMUNE RESPONSES 
As described above, there are multiple evidences 
indicating that chitin is a potent innate immune 
stimulator of macrophages and other innate 
immune cells. This raises the possibility that chitin 
could affect allergen-induced adaptive type II 
responses as well. Generally, type I cytokines are 
produced by innate immune cells and it has been 
shown that type I cytokines down-regulate type 2 
allergic immune responses.
31 In addition, the 
administration of IFN-γ  or IL-12 significantly 
inhibited Th2 driven inflammatory responses in 
allergic animal models.
32,33 Thus, it is reasonable 
to speculate that chitin could negatively modulate 
allergen-induced type 2 inflammatory responses if Chun Geun Lee 24
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chitin does stimulate type I cytokines production. 
Several studies strongly support this contention. 
Shibata et al. has elegantly demonstrated that 
orally given chitin significantly down regulates 
allergen-induced IgE production and lung inflam-
mation in a ragweed-immunized allergic animal 
model.
31 The allergen-stimulated Th2 cytokines, 
such as IL-4, IL-5, and IL-10 production was signi-
ficantly inhibited by the presence of chitin in 
spleen cell culture. They further demonstrated 
that IFN-γ produced by NK cells and ragweed- 
specific Th1 cells was responsible for the inhibi-
tion of allergen-induced Th2 cytokine produc-
tion.
31 I n  a  s e p a r a t e  s t u d y ,  t h e  s a m e  g r o u p  o f  
investigators have shown that chitin is a strong 
Th1 adjuvant that up-regulates heat-killed Myco-
bacterium bovis Calmette-Guerin bacillus (HK- 
BCG)-induced Th1 immunity, but down regulates 
mycobacterial protein (MPB-39)-induced Th2 im-
munity.
34 The Th1 adjuvant effect of chitin micro- 
particles (CMP) in inducing viral specific immu-
nity has also been reported.
35 Later studies by 
Strong et al. further demonstrated that direct 
intranasal application of chitin microparticles into 
the lung also significantly down-regulated allergic 
response to Dermatophagoids pteronyssinus (Der p) 
and  Aspergillus fumigatus in a murine model of 
allergy.
36 The chitin treatment substantially re-
duced these allergen-induced serum IgE levels, 
peripheral eosinophilia, airway hyper-responsive-
ness, and lung inflammation. They noted the 
elevation of Th1 cytokines IL-12, IFN-γ and TNF-ɑ 
and reduction in IL-4 production in the chitin- 
treated mice compared to sham controls. Similarly, 
intranasal application of water soluble chitosan 
also significanlty attenuated Dermatophagoids farinae 
(Der f)-induced lung inflammation and mucus 
production.
36 Subsequent studies by Ozdemir et 
al. further demonstrated that application of micro-
gram quantities of chitin microparticles had a 
beneficial effect in preventing and treating histo-
pathologic changes in the airways of asthmatic 
mice.
37 All these studies strongly support the 
contention that chitin negatively regulate the 
development of adaptive type 2 allergic responses. 
As a regulatory mechanism, down regulation of 
allergen-induced arginase I and thymic stromal 
lymphopoietin (TSLP) expression in the bronchial 
epithelium was suggested.
38 The significant role of 
TSLP and arginase I in Th2 polarization and tissue 
remodeling process has been previously described, 
respectively.
39,40 From the clinical point of view, 
the regulatory function of chitin on Th2 adaptive 
immune response is therapeutically important 
because it can be applied to control a variety of 
type 2 allergic diseases.
Although many studies strongly suggest that 
chitin or chitin derivatives enhance Type I immu-
nity while suppressing Type II inflammatory 
responses, a number of issues remain to be clari-
fied to generalize these effects. The animal models 
that were used to assay chitin effects in these 
studies may represent only a specific type of allergic 
response. This needs to be tested in other type 1 
as well as type 2 allergic animal models such as 
animal models using Ovalbumin (OVA) as a im-
munizing allergen.
41,42 As discussed in the above 
section,  in vivo chitin also stimulated innate 
immune cells, such as eosinophils and basophils, 
the cells that are closely associated with allergic 
responses. Type 2 cytokines produced from these 
innate immune cells can further enhance allergen- 
induced inflammatory and tissue responses. These 
studies suggest that in vivo regulation of chitin on 
adaptive Th2 immune response may not be simple 
or uni-directional. In addition, a Th2 adjuvant 
effect of chitin in a Th2 allergic animal model has 
been observed (unpublished observations). When 
viewed in combination, these studies demonstrate 
that chitin or chitin derivatives have complex in 
vivo regulatory mechanisms on adaptive immune 
responses and this necessitates clarification for 
future clinical applications of chitin in allergic 
diseases.
C/CLPS AND ALLERGIC INFLAMMATION 
The chitinases Der p 15 and Der p 18 originated 
from house dust mites have been identified as 
major dog allergens
43 and also suggested to be 
allergenic to humans.
44 The potential role of endo-
genous mammalian C/CLPs in allergic immune 
response only recently been investigated (for review 
see.
5,45 One of the prototypic chitinase AMCase 
was first noted to be induced during Th2 inflam-
mation through an IL-13-dependent mechanism.
14 
It was also shown to play an important role in the Immune Regulation of Chitin and Chitinases 25
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pathogenesis of Th2 inflammations and IL-13 
effector pathway activation.
14 In support of this 
contention, subsequent studies also demonstrated 
that potential role of AMCase in human asthma,
17 
ocular allergy,
46 and allergic airway inflamma-
tion.
47  However, in contrary to the mice system, 
recent studies demonstrated that AMCase ex-
pressed in human lung was mostly inactive and 
chitotriosidase was mainly responsible for the 
chitinase activity in the lung.
48 Thus, whether the 
chitotriosidase in humans has the same immuno-
logic activity in allergic responses as AMCase in 
mouse is an interesting question that need to be 
addressed in further studies. Recently more 
exciting stories were developed for role of CLPs 
in allergic diseases. In the mouse allergic models, 
Ym-1 and Ym-2 was recognized as a allergy-asso-
ciated protein.
44,47,49 In humans, our laboratory 
demonstrated that levels of YKL-40/BRP-39 in sera 
and lung tissues were significantly associated with 
asthma development and even severity of the 
disease.
18 Subsequent extensive population studies 
also demonstrated that YKL-40 polymorphisms are 
functionally and genetically associated with asthma 
patients,
19 suggesting an important role of YKL- 
40/BRP-39 in the pathogenesis of asthma or Th2 
allergic diseases. Interestingly, a significant role of 
YKL-40/BRP-39 in the generation of intestinal 
bowel disease (IBD) as a active pathogenic mediator 
in acute colitis has been suggested.
13,15  When viewed 
in combination, these studies provide noble insights 
on the biological role of C/CLPs in a number of 
allergic and inflammatory diseases including as-
thma, asthritis, and rhinosinusitis, and IBD. How-
ever, specific functional role of C/CLPs in allergic 
diseases remains to be defined.
C/CLPS IN TISSUE REMODELING
Recently a number of studies suggest that im-
portant role of C/CLPs in disease pathogenesis 
that characterized by pathologic tissue remodeling. 
Bargagli et al.
50 reported that significantly higher 
activity of chitotriosidase, in serum and BAL of 
patients with sarcoidosis, especially in those with 
progressing disease and lung involvement, than in 
controls. They also showed that the increase of the 
chitotriosidase activity was specific in sarcoidosis 
patients because the activity was in normal range 
in the patients with tuberclosis or with idiopathic 
pulmonary fibrosis and pulmonary fibrosis asso-
ciated with systemic sclerosis.
50,51 In addition, 
potential role of chitotriosidase in the evolution of 
nonalcoholic fatty liver disease such as non-alcoho-
lic steatohepatitis (NASH) has been suggested.
52,53 
In those studies, Kupffer cells in NASH patients 
overproduce chitotriosidase contributed to the pro-
gression from uncomplicated steatosis to steatohe-
patitis with progressive fibrosis.
53  Several studies 
also suggested that CLPs such as YKL-40 or mouse 
Ym-1 or Ym-2 could be involved in tissue remode-
ling process. Serum YKL-40 was significantly 
related to the degree of liver fibrosis and staining 
of YKL-40 antigen was higher in areas with fibrosis, 
particularly areas with active fibrogenesis.
54,55  The 
serum levels of YKL-40 was correlated with the 
stage of hepatic fibrosis in patients infected with 
S. japonicum, further support potential role of 
YKL-40 in the pathogenesis of fibrogenesis.
56 In the 
animal models that accompanying tissue remo-
deling process also demonstrated significant 
changes in the C/CLPs expression at the site of in-
flammation or remodeling. Th2-inducing pathogens 
Schistosoma mansoni and Nippostrongylus brasiliensis 
cause granulomatous inflammation and liver fib-
rosis in the infested mice. In that model, AMCase 
and Ym-1 expression were significantly increased 
along with type 2 cytokines such as IL-13 and IL- 
4.
57 In the mice with pulmonary fibrosis induced 
by crystalline silica exposure,
58 or herpesvirus
59 
also demonstrated that close associations between 
expression of C/CLPs and degree of tissue remo-
deling. However, it is still not clear whether C/ 
CLPs actively participate in the tissue remodeling 
process or indirectly modulate the process through 
regulation of other cytokines and/or growth 
factors. The elevated expression of C/CLPs could 
only represent specific type of macrophage activa-
tion, such as alternative activation of macroph-
ages, that produce a number of potent growth 
factors capable of inducing tissue remodeling. In 
this case, C/CLPs only involves in the activation 
process of macrophages and other cells. Further 
mechanistic studies using specific gene targeted 
animal models or transgenic models will be 
required to define more specific function of C/ 
CLPs in tissue remodeling. Chun Geun Lee 26
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CONTROVERSIAL AND UNSOLVED ISSUES
Macrophage activation by chitin 
The macrophages response to exogenous chitin 
is not consistent when similar studies are com-
pared. The earlier studies indicated that direct 
stimulation of macrophages with chitin or chitin 
derivatives significantly enhanced the expression 
of type I pro-inflammatory cytokines such as 
TNF-ɑ and IL-12 and IFN-γ.
21,60 Later, Shibata et 
al. further supported the contention that chitin 
stimulates macrophages to express type I cyto-
kines such as TNF-ɑ, IL-18 and IL-12 that resulted 
in the expression of IFN-γ by NK cells.
25,26 IFN-γ 
is well known cytokine that classically stimulates 
macrophages.
61 However, studies from Reese et al. 
demonstrated that chitin alternatively activated 
macrophages (AAM) that were critical for chitin- 
induced inflammatory responses.
28 It has been 
shown that chitin or chitin derivatives stimulate 
wound healing via AAM.
10 Other studies indicated 
that chitin directly stimulates macrophages to 
express TNF-ɑ and IL-17 via TLR-2 and MyD-88- 
dependent but TLR-4-independent pathways.
62 
These studies suggest a number of pathways, and 
cytokines are possibly involved in chitin-induced 
macrophages activation and cytokine production. 
Also, the discrepancies in chitin-induced macro-
phage activation between similar studies were 
possibly originated from the difference in the ex-
perimental system itself. The possibility of other 
contaminants, such as lipids or β-glucan, was 
excluded by demonstrating that chitin-induced 
responses were abolished by the treatment of 
chitin with chitinase before challenging animals.
28 
LPS contamination has been also excluded because 
the chitin-induced response was known to be TLR- 
4 independent.
28,62 However, the chitin preparation 
(size difference), doses, duration, and route of 
chitin administration could differently affect in-
flammatory and tissue responses.
9,28  When viewed 
in combination, it is more reasonable for now to 
speculate that chitin has the capacity to stimulate 
macrophages in multiple directions depending on 
experimental conditions or pathways involved. 
Chitin can interact with diverse cell surface 
receptors, such as macrophage mannose receptor, 
TLR-2 receptors,
25,62 and a C-type lectin receptor 
dectin-1 (unpublished observation). It would be 
very interesting to define specific chitin-receptor 
interactions for macrophage activation. The alter-
native activation of macrophages by chitin could 
be a secondary event followed by the initial influx 
of eosinophils or other inflammatory cells ex-
pressing type II cytokines. In this scenario, chitin 
initially activates macrophages to express pro-in-
flammatory mediators, such as LTB428, that 
recruit eosinophils and other innate immune cells 
expressing type II cytokines. Then, the macro-
phages can be alternatively activated by the cyto-
kines expressed by those inflammatory cells. To 
understand the nature of chitin-induced immune 
regulation, further characterization of underlying 
mechanisms leading to distinct macrophage acti-
vation will be required in future studies.
Chitin effects on other innate immune cells
Epithelial cells and other antigen presenting 
cells (APCs) in the airways or the gut are often 
exposed to a variety of exogenous allergens and 
potentially chitin-containing pathogens by inhala-
tion or ingestion. Epithelial cells endogenously 
express chitinases and chitin binding proteins or 
their expression is significantly induced by aller-
genic stimulation.
14,44,49 The specific role of epi-
thelial cells in chitin-induced immune response has 
not been carefully evaluated, and the effects of 
chitin on innate immune cells other than macro-
phages and NK cells remains largely unknown. 
As epithelial and dendritic cells are key players in 
allergen (or pathogen) recognition and processing, 
it is important to define the response of these cells 
to chitin to understand the immune regulatory 
function of chitin in vivo. Because dendritic cells 
express a number of toll-like receptors and C-type 
lectin receptors endogenously and in a inducible 
manner like macrophages,
63,64 it is reasonable to 
speculate that exogenous chitin can directly in-
teract with dendritic cells, and modulate functio-
nal phenotypes that lead to specific polarized T 
cell responses. It has been shown that when 
airway epithelial cells are exposed to allergen or 
injury, several alarmins, such as TSLP, along with 
pro- and anti- inflammatory cytokines are produced 
from epithelial cells, that could affect dendritic 
cell phenotypes and functions.
39 Interestingly, Immune Regulation of Chitin and Chitinases 27
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chitosan has been shown to down-regulate TSLP 
expression from allergen-stimulated epithelial 
cells,
38 suggesting potentially important roles of 
epithelial cells and dendritic cells in the immu-
nological activity of chitin. Cytokines, chemokines 
and other mediators produced from chitin stimu-
lated epithelial cells or dendritic cells will be 
interesting targets for future studies.
CHITIN INTERACTION WITH ENDOGENOUS 
CHITINASES OR CLPS
Although several in vivo and in vitro studies have 
provided substantial evidence that chitin uses cer-
tain receptors expressed on the surface of macro-
phages, the exact interacting molecule(s) has not 
yet been defined. As discussed in the previous 
section, although chitin is not produced in mam-
mals, many chitinases or CLPs are endogenously 
expressed in mammals. Chitinases and CLPs 
belong to family 18 glycosyl hydrolase members 
which contain a catalytic domain and a chitin 
binding domain.
5,65 The physical binding proper-
ties between chitin and a CLP have been charac-
terized in previous studies.
65-67  However, the exact 
role of these chitinase or chitinase-like proteins in 
the regulation of chitin-induced inflammatory and 
immune regulatory function remains to be deter-
mined. Previous studies demonstrated that the ex-
pression of a number of chitinases and CLPs were 
induced in allergic animal models and humans with 
allergic inflammation. However, it is undetermined 
whether the chitinase or CLPs expression is in-
duced or not by in vivo chitin stimulation. Recently, 
Reese et al. reported that after in vivo administra-
tion of chitin into the lungs of chitinase overex-
pressing transgenic mice, chitin-induced eosino-
phil and basophil recruitment was abolished.
28 
These studies suggest a protective role of chitinases 
against chitin or chitin-containing pathogens such 
as parasites. However, previous studies from our 
laboratory and others demonstrated significant 
induction of chitinases and CLPs in an animal 
model of allergy using non-chitin containing 
allergen such as OVA.
14,49  Chitinases and CLPs are 
also impressively induced in the lung of IL-13 
overexpressing transgenic mice, and specific in-
hibition of chitinase activity in these animal 
models using chemical (allosamidine) or neutrali-
zation antibody against specific chitinases, signifi-
cantly reduced OVA- or IL-13-induced inflamma-
tion.
14 These studies suggest that endogenous 
chitinases or CLPs could be involved in general 
host response, irrespective of chitin. When viewed 
in combination, chitin or allergen modulated the 
expression of chitinases or chitin-binding proteins, 
and these chitinases may have a direct protective 
role against chitin by degrading the chitin itself, 
but also may function to amplify inflammatory 
responses against chitin or other allergens. The 
question as to what kinds of chitinases or chitinase- 
like molecules are induced in response to exogen-
ous chitin, and how this endogenous chitinase 
family of proteins interacts with chitin in immune 
responses, is still waiting to be answered.
CONCLUSION
 A number of studies indicate that chitin and 
chitin derivatives have diverse biological activities. 
Not only the abundance of chitin in the environ-
ment or the growing use of chitin or chitin deriva-
tives in various biomedical fields but also the 
potent immunologic activity of chitin has pro-
mpted us to consider chitin as a potential pro- or 
anti-allergenic molecule. Recent studies demon-
strated that chitin primarily stimulate innate im-
mune cells to generate type I or type 2 inflam-
matory responses depending on the chitin size or 
composition and/or ways of chitin administration 
(Fig. 1). In vivo chitin also directly or indirectly 
modulates allergen-induced adaptive inflamma-
tion through a number of ways (Fig. 1). However, 
exact in vivo immune regulatory effects of chitin 
has been controversial and the underlying mecha-
nisms of chitin regulation of allergic response has 
not been clearly defined. Also a number of recent 
studies strongly suggest that C/CLPs are involved 
in the development or progression of allergic 
diseases and tissue remodeling. Further charac-
terization on the interactions between chitin and 
C/CLPs, the specific role of endogenous C/CLPs 
in allergic immune responses and tissue remo-
deling, and underlying signaling pathways will be 
required to understand the exact biological role of 
chitin, C/CLPs in the pathogenesis of allergic and Chun Geun Lee 28
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Fig. 1. Chitin stimulation of innate immune cells and regulation of adaptive allergic immune responses. Chitin or chitin 
derivatives activate macrophages to express a number of pro-inflammatory cytokines, chemokine (e.g., GCP-2) and other 
mediators (LTB4) via macrophage mannose receptor, TLR-2, and C-type lectin receptor. Then the eosinophils, basophils 
and neutrophils that are recruited by these inflammatory mediators present type II allergic responses by secretion of Th2 
cytokines (IL-4, IL-5, IL-13) and other allergic mediators (histamines, peroxidases). Thus, chitin-induced eosinophils and 
basophils further enhance allergen-induced adaptive Th2 inflammatory responses. On the other hand, many studies also 
support that chitin activates macrophages, NK cells and neutrophils to produce type I cytokines (TNF-ɑ, IL-12, IL-1β and 
IFN-γ), and suppress allergen-induced adaptive type II immune responses. Chitosan down-regulate allergen-induced TSLP 
expression from epithelial cells, and inhibits Th2 polarization by TSLP-dendritic cell interaction. The direct effect of chitin 
and chitin derivatives on dendritic cells remains to be determined.
inflammatory diseases. 
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